TherapeuticsMD, Inc. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
TherapeuticsMD, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q2 2024.
  • TherapeuticsMD, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 32M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 32M 0 0% Jun 30, 2024 10-Q 2024-08-12
Q4 2023 32M +20M +167% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 32M +20M +167% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 32M +20M +167% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 12M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 12M 0 0% Dec 31, 2022 10-K 2024-03-29
Q3 2022 12M -588M -98% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 12M -588M -98% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 12M -588M -98% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 12M -588M -98% Dec 31, 2021 10-K 2023-04-07
Q3 2021 600M 0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 600M 0 0% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 600M +250M +71.4% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 600M +250M +71.4% Dec 31, 2020 10-K 2022-03-23
Q3 2020 600M +250M +71.4% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 600M +250M +71.4% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 350M 0 0% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 350M 0 0% Dec 31, 2019 10-K 2021-03-04
Q3 2019 350M 0 0% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 350M 0 0% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 350M 0 0% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 350M 0 0% Dec 31, 2018 10-K 2020-02-24
Q3 2018 350M 0 0% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 350M 0 0% Jun 30, 2018 10-Q 2018-07-30
Q1 2018 350M 0 0% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 350M 0 0% Dec 31, 2017 10-K 2019-02-27
Q3 2017 350M 0 0% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 350M 0 0% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 350M 0 0% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 350M 0 0% Dec 31, 2016 10-K 2018-02-23
Q3 2016 350M 0 0% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 350M 0 0% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 350M +100M +40% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 350M +100M +40% Dec 31, 2015 10-K 2017-02-28
Q3 2015 350M +100M +40% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 350M +100M +40% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 250M 0 0% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 250M 0 0% Dec 31, 2014 10-K 2016-02-26
Q3 2014 250M 0 0% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 250M 0 0% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 250M 0 0% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 250M 0 0% Dec 31, 2013 10-K 2015-03-12
Q3 2013 250M 0 0% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 250M 0 0% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 250M 0 0% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 250M 0 0% Dec 31, 2012 10-K 2014-03-05
Q3 2012 250M 0 0% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 250M +200M +400% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 250M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 250M +200M +400% Dec 31, 2011 10-K 2013-03-12
Q3 2011 250M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 50M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 50M Dec 31, 2010 10-Q 2011-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.